These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15049992)

  • 41. [Advances in application of sildenafil to erectile dysfunction].
    Li Z; Wu ZM; Wang YX
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):473-6. PubMed ID: 15999498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study.
    Safarinejad MR
    J Diabetes Complications; 2004; 18(4):205-10. PubMed ID: 15207837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A 36-week, open label, non-comparative study to assess the long-term safety of sildenafil citrate (VIAGRA) in patients with erectile dysfunction.
    Goldstein I
    Int J Clin Pract Suppl; 1999 Jun; 102():8-9. PubMed ID: 10665112
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction.
    Park K; Ku JH; Kim SW; Paick JS
    BJU Int; 2005 Feb; 95(3):366-70. PubMed ID: 15679795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners.
    Brock G; Chan J; Carrier S; Chan M; Salgado L; Klein AH; Lang C; Horner R; Gutkin S; Dickson R
    BJU Int; 2007 Feb; 99(2):376-82. PubMed ID: 17155989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kidney disease quality of life of Japanese dialysis patients who desire administration of sildenafil and the treatment of erectile dysfunction using sildenafil.
    Hyodo T; Ishida H; Masui N; Taira T; Yamamoto S; Oka M; Uchida T; Endo T; Sakai T; Yoshida K; Baba S
    Ther Apher Dial; 2004 Aug; 8(4):340-6. PubMed ID: 15274687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
    Ishii N; Nagao K; Fujikawa K; Tachibana T; Iwamoto Y; Kamidono S
    Int J Urol; 2006 Aug; 13(8):1066-72. PubMed ID: 16903931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sublingual sildenafil in the treatment of erectile dysfunction: faster onset of action with less dose.
    Deveci S; Peşkircioğlu L; Aygün C; Tekin MI; Dirim A; Ozkardeş H
    Int J Urol; 2004 Nov; 11(11):989-92. PubMed ID: 15509203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-marketing surveillance study of the efficacy and safety of vardenafil among patients with erectile dysfunction in primary care.
    Kim CM; Kim YS; Sunwoo S; Cho B; Rho M; Yang YJ; Kim CH; Shin HC; Lee SY; Kim DH;
    Int J Impot Res; 2007; 19(4):393-7. PubMed ID: 17287834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra) for erectile dysfunction.
    McCullough AR; Carson CC; Hatzichristou D
    Urology; 2006 Sep; 68(3 Suppl):38-46. PubMed ID: 17011374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A modified prescription-event monitoring study to assess the introduction of Flixotide Evohaler into general practice in England: an example of pharmacovigilance planning and risk monitoring.
    Perrio MJ; Wilton LV; Shakir SA
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):969-78. PubMed ID: 17476703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of sildenafil as the first-step therapeutic tool for Japanese patients with erectile dysfunction.
    Ochiai A; Naya Y; Soh J; Ishida Y; Mizutani Y; Kawauchi A; Fujiwara T; Miki T
    Int J Impot Res; 2005; 17(4):339-42. PubMed ID: 15829991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A decade's evidence review of sildenafil citrate].
    Zhang K; Zhu JC
    Zhonghua Nan Ke Xue; 2009 Jan; 15(1):3-6. PubMed ID: 19288739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
    Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
    Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diffusion of a novel therapy into clinical practice: the case of sildenafil.
    Harrold LR; Gurwitz JH; Field TS; Andrade SE; Fish LS; Jarry PD; Yood RA
    Arch Intern Med; 2000 Dec 11-25; 160(22):3401-5. PubMed ID: 11112232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular outcomes among sildenafil users: results of the International Men's Health Study.
    Mittleman MA; Maclure M; Lewis MA; Hall GC; Moore N; Giuliano F; Porst H; Hedelin H; Martin-Morales A; Sobel RE; Reynolds R; Glasser DB
    Int J Clin Pract; 2008 Mar; 62(3):367-73. PubMed ID: 18261073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Updates on the safety of sildenafil. Mostly safe for heart patients as well].
    MMW Fortschr Med; 2002 Dec; 144(50):62-3. PubMed ID: 14610871
    [No Abstract]   [Full Text] [Related]  

  • 58. [Sildenafil, the heart patient and the cardiologist].
    Danchin N
    Arch Mal Coeur Vaiss; 1999 Oct; 92(10):1339-43. PubMed ID: 10562904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vestibular symptoms as a complication of sildenafil: a case report.
    Hamzavi J; Schmetterer L; Formanek M
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):54-5. PubMed ID: 12407937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety profile of oxcarbazepine: results from a prescription-event monitoring study.
    Buggy Y; Layton D; Fogg C; Shakir SA
    Epilepsia; 2010 May; 51(5):818-29. PubMed ID: 20132298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.